Page last updated: 2024-10-26

racemetirosine and Astroblastoma

racemetirosine has been researched along with Astroblastoma in 1 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research Excerpts

ExcerptRelevanceReference
"FMT PET is valuable for differentiating gliomatosis cerebri from non-neoplastic diseases showing similar diffuse high signal on T2-weighted images and little contrast enhancement."1.32Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography. ( Aoki, J; Endo, K; Inoue, T; Kurihara, H; Oriuchi, N; Otani, T; Sasaki, T; Sato, N; Takahashi, A; Tomiyoshi, K, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, N1
Inoue, T1
Tomiyoshi, K1
Aoki, J1
Oriuchi, N1
Takahashi, A1
Otani, T1
Kurihara, H1
Sasaki, T1
Endo, K1

Other Studies

1 other study available for racemetirosine and Astroblastoma

ArticleYear
Gliomatosis cerebri evaluated by 18Falpha-methyl tyrosine positron-emission tomography.
    Neuroradiology, 2003, Volume: 45, Issue:10

    Topics: Adult; Aged; alpha-Methyltyrosine; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorode

2003